Skip to main content
Clinical Trials/NCT00445835
NCT00445835
Completed
Not Applicable

Active Detection and Management of the Extension of Atherothrombosis in High Risk Coronary Patients In Comparison With Standard of Care for Coronary Atherosclerosis: The AMERICA Study

Assistance Publique - Hôpitaux de Paris1 site in 1 country526 target enrollmentSeptember 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
526
Locations
1
Primary Endpoint
death (all cause) or any ischemic event leading to rehospitalisation or any evidence of organ failure.
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Coronary artery disease is the first cause of death related to atherothrombosis.

Detailed Description

Coronary artery disease is the first cause of death related to atherothrombosis. There is a close correlation between the extension of coronary artery disease and the severity of atherosclerotic lesions in extra coronary arterial beds. In addition, these symptomatic extracoronary lesions dramatically decrease the survival of these patients. However, scant data are available regarding the prevalence of extracoronary asymptomatic lesions. Conversely, the annual absolute risk of these lesions remains unknown. Consequently, whether a systematic identification of these extracoronary asymptomatic lesions is relevant remains to be established. The Primary Objective and Primary Endpoint of the AMERICA study is to demonstrate the superiority of an active detection and management of the extension of atherothrombosis in high Risk coronary patients (active strategy) in comparison with standard of care for coronary atherosclerosis (conservative strategy).

Registry
clinicaltrials.gov
Start Date
September 2007
End Date
April 2013
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

death (all cause) or any ischemic event leading to rehospitalisation or any evidence of organ failure.

Time Frame: during the study

death (all cause) or any ischemic event leading to rehospitalisation or any evidence of organ failure.

Secondary Outcomes

  • Incidence of each composite of the primary endpoint.(during the study)

Study Sites (1)

Loading locations...

Similar Trials